1999American Heart JournalRequires access

Efegatran sulfate as an adjunct to streptokinase versus heparin as an adjunct to tissue plasminogen activator in patients with acute myocardial infarction

Anthony Fung, Gerald Lorch, Patrick Cambier, Dennis Schrøder Hansen, Bradley G. Titus, Jenny S. Martin, Jennifer J. Lee, Nathan R. Every, Alfred P. Hallstrom, Donna Stock-Novack, Joel Scherer, W. Douglas Weaver

Open publisher page 21 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 21 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Streptokinase, Medicine, TIMI, Heparin, Thrombolysis, Myocardial infarction, Tissue plasminogen activator, Antithrombin

Related papers

Back to paper searchBrowse research topicsOriginal source
Efegatran sulfate as an adjunct to streptokinase versus heparin as an adjunct to tissue plasminogen activator in patients with acute myocardial infarction — Research Paper | ScholarLens